The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > Fluorescein-dextran

Fluorescein-dextran

Fluorescein-dextran is a fluorescent dye that can be used as a tracer for studying various biological processes.
It consists of the fluorescent compound fluorescein covalently linked to the polysaccharide dextran.
Fluorescein-dextran is commonly used in research to visualize and quantify vascular permeability, blood flow, and tissue perfusion.
It can also be utilized to investigate lymphatic drainage and other extravascular transport pathways.
Researchers can easily locate the best protocols for using fluorescein-dextran from literature, pre-prints, and patents using PubCompare.ai's AI-driven protocol comparision tool, ensuring reproducible and accruate findings in their studies.

Most cited protocols related to «Fluorescein-dextran»

Male Sprague-Dawley rats, 270 to 310 g in mass, were used in accordance with both the local IACUC and NIH regulations. Detailed surgical procedures are described elsewhere (Helmchen and Kleinfeld, 2008 (link); Shih et al., 2008 ). In brief, anesthesia was maintained with 1 to 2 % (v/v) isoflurane in 30 % (v/v) oxygen and 70 % (v/v) nitrous oxide. Cranial windows, 4 × 4 mm in size and centered at 4.5 mm lateral and −3.0 mm caudal, were constructed as described previously (Kleinfeld et al., 2008 ). Images were collected using a two-photon laser scanning microscope of local design (Tsai et al., 2002 ; Tsai et al., 2003 (link); Tsai and Kleinfeld, 2009 ) that was controlled by MPScope software (Nguyen et al., 2006 (link); Nguyen et al., 2009 ). The vasculature was visualized by circulating 2MDa fluorescein-dextran (FD2000S, Sigma), as described previously (Schaffer et al., 2006 ). The flow of RBCs is visualized as dark objects against the fluorescent plasma background. A 40x magnification water-dipping objective (Olympus America, Center Valley, PA) was used to obtain the line-scan data. Scans were collected along the centerline of each vessel over a length of 70 to 250 pixels, which spanned 7 to 76 μm, at a scan rate of 1.6 kHz per line.
Publication 2009
Anesthesia Blood Vessel Cranium Erythrocytes fluorescein-dextran Institutional Animal Care and Use Committees Isoflurane Laser Scanning Microscopy Males Operative Surgical Procedures Oxide, Nitrous Oxygen Plasma Radionuclide Imaging Rats, Sprague-Dawley
In all experiments, intestinal permeability was induced using FR as previously published (12 (link), 13 (link)). Chickens were randomly assigned to each experimental group and had unrestricted access to feed and water from 1 to 10 days of age. Beginning at 10 days, chickens in control FITC-d groups were allowed to continue with ad libitum access to feed, while chickens in FR FITC-d groups were subjected to 24 h of FR. Concentration of FITC-d was given based on group body weight; therefore, groups were weighed the day before FR began. At 11 days of age, chickens in all groups were given an appropriate dose of FITC-d by oral gavage for each experiment. After 1 h, or 2.5 h respectively, chickens were euthanized with CO2 asphyxiation. Blood samples were collected from the femoral vein to quantify levels of FITC-d.
Full text: Click here
Publication 2017
Asphyxia BLOOD Body Weight Chickens Fluorescein-5-isothiocyanate Intestines Permeability Tube Feeding Vein, Femoral
The experiments were carried out on thirteen (3.5–6.9 years old) rhesus (Macaca mulatta) or cynomolgus (Macaca fascicularis) monkeys (male or female, 3.0–5.0 kg; see Table 1), in accordance to the Guide for Care and Use of Laboratory Animals (ISBN 0-309-05377-3; 1996) and approved by local veterinary authorities, including the ethical assessment by the local (cantonal) Survey Committee on Animal Experimentation and a final acceptance delivered by the Federal Veterinary Office (BVET, Bern, Switzerland). The monkeys were obtained from our own colony in our animal facility (Macaca fascicularis) or were purchased (Macaca fascicularis and Macaca mulatta) from a certified supplier (BioPrim; 31450 Baziège; France), with the authorization to import the animals delivered by the Federal Veterinary Office (BVET, Bern, Switzerland). Three recent reports (Wannier et al., 2005 (link); Freund et al., 2006a (link), 2007 (link)) describe the behavioral task analyzed in the present report (‘modified Brinkman board’ task; see Fig. 1E and also http://www.unifr.ch/neuro/rouiller/motorcontcadre.htm), the surgical procedures (including transection of the CS tract in the cervical cord at C7/C8 level), the treatment with the anti-Nogo-A (n = 7) or control (n = 6) antibodies and the neuroanatomical investigations (including assessment of spinal lesion location and extent). The antibodies’ characteristics and penetration in the central nervous system have been reported elsewhere (Weinmann et al., 2006 (link); Freund et al., 2007 (link)). As previously reported in detail (Schmidlin et al., 2004 (link), 2005 (link); Wannier et al., 2005 (link); Freund et al., 2006a (link), 2007 (link)).
The present study includes the same twelve previously reported monkeys (Freund et al., 2006a (link), 2007 (link)) and a thirteenth monkey (Mk-AK), on which the experiment was completed later, and in which anti-Nogo-A antibody infusion was initiated 7 days post-lesion (Fig. 1A), in contrast to immediate infusion the day of the lesion in the other six anti-Nogo-A antibody-treated monkeys. However, in this thirteenth monkey (Mk-AK), although an osmotic pump was implanted immediately after the lesion (as was the case for all the other monkeys), only saline (NaCl 0.9%) was delivered during the first week, and delayed administration of the anti-Nogo-A antibody started 1 week post-lesion. In all cases, the antibody was delivered for a period of 4 weeks.
The monkeys’ identification codes refer to individual monkeys (Table 1 in Freund et al., 2006a (link)) and comprise, for the sake of clarity, a ‘C’ or an ‘A’ in the fourth character position, indicating whether the monkey was control antibody-treated or anti-Nogo-A antibody-treated, respectively. However, during the course of the experiments the animals had different names from which the experimenter could not deduce which antibody was infused, at least for the monkeys in which the experimenter-blind procedure was applied (Table 1).
Monkeys were housed in our animal facilities in rooms of 12 m3, each usually containing 2–4 monkeys free to move in the room and to interact with each other. In the morning, before behavioral testing, the animal keeper placed the monkeys in temporary cages for subsequent transfer to the primate chair. The monkeys had free access to water and were not food-deprived. The rewards obtained during the behavioral tests represented the first daily access to food. After the tests, the monkeys received additional food (fruits and cereals). The dexterity of each hand was assessed in all lesioned monkeys with a finger prehension task, specifically our modified Brinkman board quantitative test (Fig. 1E; see also Rouiller et al., 1998 (link); Liu & Rouiller, 1999 (link); Schmidlin et al., 2004 (link)). The tests were conducted using a Perspex board (10 cm × 20 cm) containing 50 randomly distributed slots, each filled with a food pellet at the beginning of the test (home-made behavioral apparatus). Twenty-five slots were oriented horizontally and twenty-five vertically. The dimensions of the slots were 15 mm long, 8 mm wide and 6 mm deep. Retrieval of the food pellets required fractionated finger movements, in order to produce an opposition of the index finger and the thumb, which corresponds to the precision grip. This manual prehension dexterity task was executed daily, alternatively with one and the other hand, four or five times per week for several months before and after the unilateral cervical cord lesion. A daily behavioral session typically lasted 60 min. The performance of each hand was videotaped. In the present study, two parameters were assessed: (i) the retrieval score, i.e. the number of wells from which the food pellets were successfully retrieved and brought to the mouth during 30 s, separately for the vertical and the horizontal slots; (ii) the contact time, defined as the time of contact (in s) between the fingers and the pellet, calculated for the first vertical slot and the first horizontal slot targeted by the monkey in a given daily session (see also paragraph 2 in the Results section). The contact time is comparable to the prehension time as introduced by Nishimura et al. (2007) (link) in parallel to the present study, but for a different grasping task. In our previous study, the retrieval score represented the primary outcome measure from the modified Brinkman board task (Freund et al., 2006a (link)) and was determined by the total number of pellets retrieved in 30 s. In the present study separate scores are provided for vertical and horizontal slots. The contact time data and the bivariate and trivariate statistical analyses (see below) represent secondary outcome measures from the modified Brinkman board task, newly introduced in the present report.
After the monkeys reached a level of performance corresponding to a plateau (usually after 30–60 days of initial training), we used the score from 30–50 daily sessions to establish a pre-lesion behavioral score for each monkey. A unilateral cervical cord lesion was performed in thirteen monkeys as follows. Intramuscular injection of ketamine (Ketalar® Parke-Davis, 5 mg/kg, i.m.) was delivered to induce anesthesia followed by an injection of atropine (i.m.; 0.05 mg/kg) to reduce bronchial secretions. In addition, before surgery, the animal was treated with the analgesic Carprofen (Rymadil®, 4 mg/kg, s.c.). A continuous perfusion (0.1 ml/min/kg) through an intravenous catheter placed in the femoral vein delivered a mixture of 1% propofol (Fresenius®) and a 4% glucose solution (1 volume of propofol and 2 volumes of glucose solution) to induce a deep and stable anesthesia. The animal's head was placed in a stereotaxic headholder, using ear bars covered at their tip with local anesthetic. The surgery was carried out under aseptic conditions, with continuous monitoring of the following parameters: heart rate, respiration rate, expired CO2, arterial O2 saturation and body temperature. In early experiments, an extra intravenous bolus of 0.5 mg of ketamine diluted in saline (0.9%) was added at potentially more painful steps of the surgical procedure (e.g. laminectomy) whereas, in later experiments, ketamine was added to the perfusion solution and delivered throughout surgery (0.0625 mg/min/kg). The animal recovered from anesthesia 15–30 min after the propofol perfusion was stopped, and was treated post-operatively with an antibiotic (Ampiciline 10%, 30 mg/kg, s.c.). Additional doses of Carprofen were given daily (pills of Rymadil mixed with food) for about 2 weeks after the surgery. Following the cervical cord lesion, the animal was kept alone in a separate cage for a couple of days in order to perform a careful survey of its condition. The details of surgical procedures and lesioning are available in previous reports (Schmidlin et al., 2004 (link), 2005 (link); Wannier et al., 2005 (link); Freund et al., 2006a (link), 2007 (link)).
After lesion, and following the period of recovery lasting generally 30–40 days, a post-lesion level of performance corresponding to a plateau was established, based on a block of ten behavioral sessions (usually the last ten sessions conducted). For the retrieval score, functional recovery was expressed quantitatively as the ratio (expressed as a percentage) of the post-lesion average retrieval score value to the pre-lesion average score value. Because contact time was measured only for the first vertical and first horizontal slots targeted by the monkey, in order to minimize the impact of outliers the pre-lesion and post-lesion contact time was assessed as the median value (Fig. 3C and D). Considering that good performance is reflected by a short contact time (in the pre-lesion condition), post-lesion performance (recovery) was expressed quantitatively as the ratio (expressed as a percentage) of the pre-lesion median contact time to the post-lesion median contact time. For measures of both recovery of score and contact time, if the calculated values exceeded 100% (i.e. post-lesion performance was better than pre-lesion performance), the recovery was considered to be complete and therefore expressed quantitatively as 100%.
Besides the new behavioral parameter of contact time introduced here, the present study also comprises a new analysis regarding the lesion size. In our previous reports (Freund et al., 2006a (link), 2007 (link)), the extent of the lesion was expressed as a percentage of the corresponding hemi-cord surface, as assessed from a 2-D reconstruction of the lesion in the transverse plane (see Fig. 1B and C). These standard values of lesion extent have been considered here again in Figs 2 and 4 (see also Table 1). The present study expands upon these data by further calculating the estimated volume of the cervical lesion in order to consider the extent of the lesion in 3-D. After completion of the post-lesion behavioral analysis (see below), the monkeys were killed and prepared for histology as follows. Each monkey was pre-anaesthetized with ketamine (5 mg/kg, i.m.) and given an overdose of sodium pentobarbital (Vetanarcol; 90 mg/kg, i.p.). Transcardiac perfusion of saline (0.9%) was followed by paraformaldehyde (4% in phosphate buffer 0.1 m, pH 7.4), and 10, 20 and 30% solutions of sucrose in phosphate buffer. The brain and the spinal cord were dissected and stored overnight in a solution of 30% sucrose in phosphate buffer. Frozen sections (50 μm thick) of the cervical cord (approximately segments C6-T3) were cut in the parasagittal longitudinal plane and collected in three series for later histological processing (see below).
Using an ad hoc function of the Neurolucida software (based on the Cavalieri method; MicroBrightField, Inc., Colchester, VT, USA), the volume of the cervical lesion (in mm3) was extrapolated from the reconstructions of the lesion on consecutive histological longitudinal sections of the cervical cord (see Table 1). The volume measurement of the cervical lesion was conducted on one out of three series of sagittal sections (50 μm thick), treated immunocytochemically with the SMI-32 antibody (Covance, Berkeley, CA, USA), as previously reported (Liu et al., 2002 (link); Beaud et al., 2008 (link); Wannier-Morino et al., 2008 (link)). The epitope recognized by the SMI-32 antibody lies on nonphosphorylated regions of neurofilament protein and is only expressed by specific categories of neurons (Campbell & Morrison, 1989 (link); Tsang et al., 2006 (link)). The other two series of sections were processed to visualize biotinylated dextran amine (BDA; Invitrogen, Molecular Probe, Eugene, OR, USA) and fluorescein dextran amine (Invitrogen, Molecular Probe, Eugene, OR, USA) staining, resulting from injections of BDA in the contralesional motor cortex and fluorescein dextran amine in the ipsilesional motor cortex (see Freund et al., 2006a (link), 2007 (link)). Measurements of volume of the cervical lesion were also conducted on sections processed for BDA but the lesion contour was not as well defined as on the SMI-32-stained sections, where a clear scar region could be distinguished from a penumbra lesion at the periphery of the lesion (yellow and red outlines in Fig. 1D). The scar region was characterized by a dense fibrous tissue or granulous tissue forming a central zone of the lesion where the SMI-32 staining was absent. The lesion volume data presented (Table 1, Fig. 5) and considered for statistical analysis (Table 2) are the measurements corresponding to the scar as seen on the SMI-32-stained sections.
Because of the limited number of animals, two independent statistical tests were used to compare the group of control antibody-treated monkeys (n = 6) with the group of anti-Nogo-A antibody-treated monkeys (n = 7). The first test (based on a linear Fisher discriminant analysis) takes into account one of the two parameters reflecting the size of the lesion (i.e. the extent of hemi-cord lesion or the volume of the lesion) and one of the four parameters reflecting the percentage of functional recovery (score for vertical slots, score for horizontal slots; contact time for vertical slots or contact time for horizontal slots), and thus is aimed at assessing the overlap or segregation between the two groups of data (Figs 2E and F, and 4C and D). The test provides maximal separation between the groups (see Everitt, 2005 ) in the form of a linear function of the observed variables such that the ratio of the between-groups variance to its within-group variance is maximized. We used the R package to get the two lines plotted in each of Figs 2E and F, and 4C and D. Line 1 (dashed line) yields maximal separation and the projected samples are provided on the orthogonal line 2 (solid line). For better visualization, line 2 was proportionally enlarged and positioned vertically on the right side of the graph (green arrows). With respect to the statistics, the sample size does not permit an assumption of normality so we considered the statistical problem of separation of the projected samples using the nonparametric Mann–Whitney U-test. The obtained results are summarized in Table 2 (row A, bivariate analysis).
The second statistical test (the trivariate analysis) examined the three-dimensional data produced by differences in ‘recovery of scores’ (number of pellets retrieved, as illustrated in Fig. 2), ‘recovery of contact time’ (time to grasp first pellet, as illustrated in Fig. 4) and ‘lesion extent’, using a nonparametric multivariate rank test (Oja & Randles, 2004 ). This test includes all three parameters and can be considered an index of overall functional recovery. We assumed two independent random samples from bivariate distributions F(x-c1) and F(x-c2) located at centers c1 and c2, and tested the null hypothesis that there was no effect of treatment (i.e. c1 = c2 versus the alternative c1 is different from c2). Data were transformed to make the test affine-invariant, to ensure a consistent performance over all possible choices of coordinate system, and then projected onto a sphere where a rank test was performed. As the law for this test is still unknown, we used Monte-Carlo simulations to compute the P-value. The obtained results are summarized in Table 2 (row B, trivariate analysis). A complete description of these bivariate and trivariate statistical analyses, applicable also to other types of lesions and to other behavioral tests of manual dexterity in primates, will be reported elsewhere in a methodological report. The same two statistical analyses (bivariate and trivariate tests) were applied in a similar way as above for the estimated volume of the lesion (Table 2, rows C and D).
Full text: Click here
Publication 2009
The Stanford Administrative Panel on Laboratory Animal Care approved all procedures. We used male CD-1 wild type mice 7-14 weeks old and performed surgery using isoflurane (1.5–2.5%; mixed with 1–2 l/min O2) anesthesia as previously described6 (link),9 (link). In brief, 1–6 days prior to imaging we exposed and cleaned the skull above cerebellum. (See Supplementary Note 1 regarding the hippocampal preparation). Using dental acrylic (Coltene/Whaledent, H00335) we fixed to the skull a custom metal plate allowing cranial access. On the imaging day, we opened a craniotomy (1.5–2.5 mm diameter; 6.5 mm posterior to bregma; 0.5 mm lateral) and irrigated the exposed tissue with warm artificial cerebral spinal fluid (ACSF; 125 mM NaCl, 5 mM KCl, 10 mM D-Glucose, 10 mM HEPES, 2 mM MgSO4, 2 mM CaCl2, pH adjusted to 7.4 with NaOH). To dampen heartbeat- and breathing-induced brain motion, we filled the craniotomy with agarose (2%; Type III-A, high EEO; Sigma) in ACSF and covered it with a coverslip fixed to the head plate, creating an optical window. We sealed the coverslip edges with dental acrylic. In Ca2+ imaging experiments, we left the dura intact for Ca2+ indicator injections but then removed it prior to agarose application.
In Ca2+ imaging studies, we labeled cerebellar cortex by multi-cell bolus-loading using the Ca2+-indicator Oregon-Green-488-BAPTA-1-acetoxymethyl (OGB-1-AM)6 (link),9 (link). Concentrations of OGB-1-AM and DMSO in our pipette solution were 500 μM and 5%, respectively. In microcirculatory studies, we labeled the blood plasma by injection into a tail vein of 0.15–0.25 ml fluorescein-dextran (Sigma, FD2000S, 2000 kDa, 10 mg/ml)6 (link).
We positioned the miniature microscope above the optical window and lowered it towards the brain using a translation stage, until fluorescent surface structures were visible under weak illumination (90–200 μW). After locating a suitable recording site and focal depth, we turned the illumination off and fixed the microscope to the metal head plate using Cerebond™ adhesive (myNeuroLab.com, 39465030) and dental acrylic (Henry Schein, 5478203EZ). We allowed the mouse to recover from anesthesia before placing it into the behavioral arena. Imaging began once the mouse exhibited vigorous locomotor activity, typically 15-60 min after removal from isoflurane. To minimize the possibility of photo-induced alterations in physiology, the duration and mean power of continuous illumination were typically < 5 min and ∼170-600 μW at the specimen plane for each recording. There were at least 2 min between recordings, and the total recording duration was typically < 45 min. In Ca2+ imaging experiments, we assessed tissue health before and after imaging using an upright two-photon microscope equipped with a 20× water-immersion objective (Olympus, 0.95 NA, XLUMPlanFl) and an ultra-short pulsed Ti:sapphire laser (Tsunami, Spectra-Physics) tuned to 800 nm. The frame acquisition rates of the integrated microscope were 100 Hz for studies of microcirculation and 30–46 Hz for Ca2+ imaging studies.
For studies of freely moving mice, we placed the mouse into a 45 cm × 45 cm × 15 cm arena made of transparent acrylic. A thin layer of bedding, a few food pellets, and an exercise wheel (Bio-Serv, K3250 and K3328) were inside the arena to provide a comfortable environment for the mouse. To record mouse behavior, we used either a video rate monochrome CMOS camera (Prosilica, EC640) with a high-resolution lens (Computar, M0814-MP2) situated above the arena or a video rate color CCD camera (Sony, DCR-VX2000NTSC) placed adjacent to the arena. We used two sets of infrared LED arrays (Lorex, VQ2120) for illumination with the overhead camera, but simply dim room lighting with the color camera.
Publication 2011
To determine the change in vessel diameter upon sensory stimulation when artery walls were labeled with Alexa 633, we first used a Gaussian filter (σ ≈ 1 μm) to smooth each imaging frame of the time series. Vessel cross-sections were then selected manually using a graphical user interface. When vessels were imaged longitudinally (Fig. 1a,c,e), the cross-section was drawn perpendicular to the two parallel lines that represented each side of the vessel wall. When a vessel was imaged transversely (Fig. 2a), cross-section line segments passed through the center of the circular vessel. Because Alexa 633 labeled the arterioles brightly with minimal dye in the lumen of the vessel and the brain parenchyma (Fig. 1), the profile of image brightness along the cross-section line segment always had only two maxima. Each maximum corresponded to each side of the vessel. The distance between the two maxima of each cross-section line segment represented the diameter of the vessel. The above procedures were used to calculate the diameter in each imaging frame of the time series, resulting in a time course of vessel dilation for each cross-section examined (for example, Figs. 1h and 2d,g,h). The Lilliefors test for normality was satisfied for all vessels examined. Vessels selectively tuned for particular receptive field location was defined by ANOVA across n stimulus periods (P < 0.05). Typically, our two-photon imaging frame rates for vessel imaging were slow (1–1.64 s frame−1) but well within the range used in our previous calcium imaging work5 (link)–7 (link). With faster imaging frame rates (0.16–0.2 s frame−1) we could extract the latency of arteriole dilation relative to the onset of the grating visual stimulus. To determine the latency of dilation upon sensory stimulation, each of n baseline and m stimulus frames were averaged across all repeats. We then performed a linear regression on the rising phase of the vessel dilation response using data points between 20% and 80% to the peak dilation11 (link) (for example, Fig. 1h). Visually evoked latencies of dilation for arterioles ranged from 0.67 s to 0.99 s (n = 3 arteriole branches in two mice and 5 arteriole branches in two rats). To quantify the change in vessel diameter upon sensory stimulation when the lumen of veins and arteries were labeled with fluorescein dextran, we applied the same Gaussian smoothing as described above for Alexa 633–labeled walls. However, maxima with fluorescein dextran labeling did not necessarily correspond with the vessel diameter because the lumen could have near equal brightness at more than two points along the cross-section line segment. Thus, for fluorescein dextran labeling, we calculated the first derivative of the profile of image brightness along the cross-section line segment. The first derivative had a maximum at the wall-lumen interface. Red blood cell velocity was determined from line scans of fluorescein dextran– (or Alexa 633–) labeled lumen of the blood vessel of interest (Supplementary Fig. 19). We used the Radon transform to calculate velocity (in millimeters per second) as described previously16 (link). Typically, we calculated the average velocity per block of 300 sequential line scans with an overlap of 100 lines between blocks. The algorithm was implemented using the Matlab function ‘radon’. The time courses of visual stimulus evoked velocity responses (blank versus stimulation periods; for example, Fig. 2f) were smoothed by a 10-point sliding mean.
Publication 2012

Most recents protocols related to «Fluorescein-dextran»

Mice were anesthetized with tribromoethanol and then transcardially perfused with 4% paraformaldehyde (PFA) (Electron Microscopy Services, Cat#15714) and 3mg/mL 70kDa fluorescein isothiocyanate–dextran (Millipore-Sigma, Cat#FD70S) in PBS. Eye globes were excised, and retinas were immediately dissected and flat mounted. Flat mounts were imaged with a Leica DMi8 inverted microscope within 30 minutes of harvest using a GFP filter by taking 10µm step z-stacked imaged to encompass the entire tissue at 10x magnification. The presence of leaks and avascular areas were recorded. Tissue integrity was assessed by bright field microscopy.
Publication Preprint 2024
On the 22nd day of age, 3 birds per pen (12/group) were weighted and submitted to feed restriction for 12 h to induce a gut permeability challenge. Fluorescein isothiocyanate dextran (FITC-d, 100 mg, MW 4000; Sigma-Aldrich, St. Louis, MO, USA) was utilized to assess intestinal permeability, following the method described by Baxter et al. [4 (link)]. In particular, birds were orally administered FITC-d dissolved in phosphate-buffered saline (PBS). Three additional birds per group were gavaged by PBS only and were used as serum blank controls for each group, as previously outlined [4 (link)]. In each group, subsequently, after a 2 h duration, blood samples were collected from the jugular vein and left at room temperature for 3 h before undergoing centrifugation (500× g for 15 min) to obtain the serum. The serum was then diluted with PBS (1:1 PBS), and the presence of FITC-d in the serum was quantified using a multi-mode microplate fluorescence reader (Perkin-Elmer, Waltham, MA, USA) at an excitation wavelength of 485 nm and an emission wavelength of 528 nm. The standard curve was plotted according to absorption of standards prepared by spiking FITC-d at a range of concentrations (0–0.5 μg/mL). The amount of FITC-d in the serum for each bird was reported as µg of FITC-d per milliliter of serum.
Full text: Click here
Publication 2024

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2024
The rats were anesthetized and fluorescein isothiocyanate-Dextran (FITC-D) (Sigma-Aldrich Corp, USA) was injected into the tail vein. Retinas and eyecups were isolated and tiled on glass slides, and fluorescence images were captured with a fluorescence microscope (Nikon). The specific operation method is carried out according to the previously reported scheme [20 (link)].
Full text: Click here
Publication 2024
On Day 0, 12-well Transwell inserts were coated with 10 μg/ml human recombinant laminin 511-E8 in sterile PBS or 10 μg/ml BSA control coating, and left to dry for 1 h at 37 °C. After coating, H69 cholangiocytes were seeded in the apical compartment at 100,000 cells per insert. On Day 4, PBMCs were isolated from healthy volunteers, and T lymphocytes were activated with PMA and ionomycin, after which 200,000 cells were added to the basolateral compartment. The apical compartment was refreshed with H69 culture medium and the basolateral compartment contained supplemented IMDM with or without activated T lymphocytes. Co-culture was left overnight. On Day 5, 4 kDa fluorescein isothiocyanate (FITC)-Dextran permeability assays were performed. For this, medium was refreshed with 800 μl DMEM supplemented with 10% FBS and 37.5 U/ml (1%) penicillin, 37.5 μg/ml (1%) streptomycin on the basolateral side, and 250 μl of supplemented DMEM containing 1 mg/ml 4 kDa FITC–Dextran on the apical side. At timepoint 0, 100 μl of medium was transferred to a black 96-well plate to determine potential background fluorescence. In addition, an empty unseeded Transwell insert was included to determine maximal permeability of the insert itself. At t = 60, 120, 180, and 240 min, 100 μl of basolateral medium was collected per experimental condition and transferred to the black 96-well plate. FITC–Dextran fluorescence (excitation 490 nm, emission 520 nm) was measured using the CLARIOstar apparatus.
Full text: Click here
Publication 2024

Top products related to «Fluorescein-dextran»

Sourced in United States, Germany, United Kingdom, Sao Tome and Principe, Japan, China, Macao, Spain, Switzerland, France, Italy, Australia, Israel, Sweden, Belgium, Canada
FITC-dextran is a fluorescent labeled dextran compound. It is a water-soluble carbohydrate polymer that is covalently linked to the fluorescent dye fluorescein isothiocyanate (FITC). FITC-dextran is commonly used as a tracer or marker in various biological applications.
Sourced in United States, United Kingdom, Germany
Fluorescein isothiocyanate-dextran is a fluorescent dye-labeled polysaccharide compound. It is used as a tracer molecule in various research and analytical applications.
Sourced in United States, Germany, Sao Tome and Principe, United Kingdom
Fluorescein isothiocyanate (FITC)-dextran is a fluorescently-labeled dextran compound. It is a water-soluble, high-molecular-weight carbohydrate polymer that is conjugated with the fluorescent dye FITC. This compound is commonly used as a tracer and marker in various biological and biomedical applications.
Sourced in United States
Dextran fluorescein is a fluorescent dye-labeled polysaccharide. It is commonly used as a molecular weight marker and tracer in various biological applications, such as cell and tissue staining, flow cytometry, and microscopy.
Sourced in United States, Canada, Sweden, Australia
FITC-d is a fluorescein isothiocyanate (FITC) conjugated dextran. It is a water-soluble compound used as a fluorescent label for various biological applications.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, India, Macao, Israel, Singapore, Switzerland, Senegal, Hungary, Brazil, Ireland, Australia, Japan, Czechia
FITC is a fluorescent dye used in various laboratory applications. It is a green-fluorescent dye that is commonly used for labeling and detecting biomolecules, such as proteins, antibodies, and nucleic acids. FITC emits light in the green region of the visible spectrum when excited by a suitable light source.
Sourced in United States
FITC-dextran is a fluorescently labeled polysaccharide used as a molecular probe in various biological applications. It consists of dextran, a branched glucan, conjugated with the fluorescent dye fluorescein isothiocyanate (FITC). FITC-dextran can be used to study molecular interactions, cell permeability, and other processes involving the movement of molecules in biological systems.
Sourced in United States, Germany
FITC-labeled dextran is a fluorescent marker used in laboratory experiments. It consists of dextran, a polysaccharide, conjugated with fluorescein isothiocyanate (FITC), a fluorescent dye. This product can be used to track the movement and distribution of molecules or cells in various biological systems.
Sourced in United States, Germany, United Kingdom, Italy, Switzerland, Portugal, Japan, China, France, Australia, Holy See (Vatican City State), Spain
The Synergy HT is a multi-mode microplate reader from Agilent Technologies. It is designed to perform absorbance, fluorescence, and luminescence measurements on microplates. The Synergy HT provides reliable data for a wide range of applications, including cell-based assays, ELISA, and other microplate-based experiments.
Sourced in United States, Germany, Sao Tome and Principe
FITC-conjugated dextran is a fluorescently labeled polysaccharide compound used in various biological and biomedical applications. It is composed of dextran molecules covalently linked to fluorescein isothiocyanate (FITC) dye. This product can be utilized for cell labeling, tracer studies, and other research purposes where a fluorescent marker is required.

More about "Fluorescein-dextran"

Fluorescein-dextran, also known as FITC-dextran, FITC isothiocyanate-dextran, or Dextran fluorescein, is a versatile fluorescent tracer used extensively in biological research.
This polysaccharide-based compound consists of the fluorescent dye fluorescein covalently linked to the polymer dextran.
Fluorescein-dextran is commonly employed to visualize and quantify vascular permeability, blood flow, and tissue perfusion.
It can also be utilized to investigate lymphatic drainage and other extravascular transport pathways.
Researchers often use Fluorescein-dextran in conjunction with techniques like fluorescence microscopy, flow cytometry, and the Synergy HT microplate reader to gather valuable insights into various biological processes.
The use of Fluorescein-dextran as a tracer offers several advantages, including its ability to remain within the vascular system, its low toxicity, and its ease of detection.
Researchers can easily locate the best protocols for using Fluorescein-dextran from literature, pre-prints, and patents using PubCompare.ai's AI-driven protocol comparison tool, ensuring reproducible and accruate findings in their studies.